ADVFN Logo ADVFN

We could not find any results for:
Make sure your spelling is correct or try broadening your search.

Trending Now

Toplists

It looks like you aren't logged in.
Click the button below to log in and view your recent history.

Sign Up

Already a member? Sign in

Options Flow

Live Options Flow

Market Data
News
Trading Tools
Markets
Discover

Hot Features

Follow Feed

Connect with traders and investors in our Follow Feed community.

Options Flow

Explore comprehensive options data and use advanced filters with Options Flow.

Monitor

Organize and monitor your stock and asset watchlist with Monitor.
Sign In Premium IconPremium Help Menu
S&P TSX Capped Composite...
35.04
0.60%
US Tech 100
17,442.00
2.14%
S&P 500
5,127.79
1.26%
US Dollar vs CAD
1.36715
0.03%
Bitcoin
62,924.27
0.06%
Registration Strip Icon for pro Trade like a pro: Leverage real-time discussions and market-moving ideas to outperform.
Get Started
  1. Home
  2. Investing
  3. Stocks
  4. UK
  5. LSE
  6. Immunovia Ab (publ) (0G8X)

  7. Immunovia Ab (publ) (0G8X) News

0G8X

Immunovia Ab (publ) (0G8X)

Immunovia Ab (publ)
Date:
Sort by:
 Showing the most relevant articles for your search:LSE:0G8X
DateTimeSourceHeadlineSymbolCompany
01/04/20249:59AMPR Newswire (US)Immunovia announces financial calendar for financial year 2024LSE:0G8XImmunovia Ab (publ)
01/04/20249:58AMPR Newswire (US)Immunovia announces financial calendar for financial year 2024LSE:0G8XImmunovia Ab (publ)
11/21/20234:40AMPR Newswire (US)Bulletin from the extraordinary general meeting in Immunovia ABLSE:0G8XImmunovia Ab (publ)
11/21/20234:38AMPR Newswire (US)Bulletin from the extraordinary general meeting in Immunovia ABLSE:0G8XImmunovia Ab (publ)
11/09/20232:03AMPR Newswire (US)Immunovia Publishes Interim Report for January-September 2023LSE:0G8XImmunovia Ab (publ)
11/09/20231:59AMPR Newswire (US)Immunovia Publishes Interim Report for January-September 2023LSE:0G8XImmunovia Ab (publ)
11/07/20239:14AMPR Newswire (US)Immunovia successfully completes discovery phase of next-generation test developmentLSE:0G8XImmunovia Ab (publ)
11/07/20239:12AMPR Newswire (US)Immunovia successfully completes discovery phase of next-generation test developmentLSE:0G8XImmunovia Ab (publ)
11/02/20235:02AMPR Newswire (US)Invitation to Immunovia's Q3 presentationLSE:0G8XImmunovia Ab (publ)
11/02/20235:00AMPR Newswire (US)Invitation to Immunovia's Q3 presentationLSE:0G8XImmunovia Ab (publ)
10/27/20232:06AMPR Newswire (US)CONVENING NOTICE - EXTRAORDINARY GENERAL MEETING IN IMMUNOVIA AB (PUBL)LSE:0G8XImmunovia Ab (publ)
10/27/20232:03AMPR Newswire (US)CONVENING NOTICE - EXTRAORDINARY GENERAL MEETING IN IMMUNOVIA AB (PUBL)LSE:0G8XImmunovia Ab (publ)
10/03/20234:01AMPR Newswire (US)Nomination Committee appointed for Immunovia AB (Publ)LSE:0G8XImmunovia Ab (publ)
10/03/20233:56AMPR Newswire (US)Nomination Committee appointed for Immunovia AB (Publ)LSE:0G8XImmunovia Ab (publ)
08/30/20235:30AMPR Newswire (US)Immunovia Publishes Interim Report for January-June 2023LSE:0G8XImmunovia Ab (publ)
08/30/20231:56AMPR Newswire (US)Immunovia Publishes Interim Report for January-June 2023LSE:0G8XImmunovia Ab (publ)
08/23/20231:08PMPR Newswire (US)Invitation to Immunovia's Q2 presentationLSE:0G8XImmunovia Ab (publ)
08/23/20231:06PMPR Newswire (US)Invitation to Immunovia's Q2 presentationLSE:0G8XImmunovia Ab (publ)
07/19/202311:47AMPR Newswire (US)Immunovia announces updated financial calendarLSE:0G8XImmunovia Ab (publ)
07/12/20232:15AMPR Newswire (US)Immunovia to Significantly Restructure to Focus Resources on its Next-Generation Blood Test for Pancreatic Cancer DetectionLSE:0G8XImmunovia Ab (publ)
07/12/20232:12AMPR Newswire (US)Immunovia to Significantly Restructure to Focus Resources on its Next-Generation Blood Test for Pancreatic Cancer DetectionLSE:0G8XImmunovia Ab (publ)
06/09/20233:19AMPR Newswire (US)Chief Executive Officer, Jeff Borcherding, buys Immunovia sharesLSE:0G8XImmunovia Ab (publ)
06/09/20233:11AMPR Newswire (US)Chief Executive Officer, Jeff Borcherding, buys Immunovia sharesLSE:0G8XImmunovia Ab (publ)
05/31/20235:16AMPR Newswire (US)Change in number of shares and votes in Immunovia AB (publ)LSE:0G8XImmunovia Ab (publ)
05/31/20235:13AMPR Newswire (US)Change in number of shares and votes in Immunovia AB (publ)LSE:0G8XImmunovia Ab (publ)
05/26/20236:43AMPR Newswire (US)Bulletin from the Annual General Meeting in Immunovia ABLSE:0G8XImmunovia Ab (publ)
05/26/20236:41AMPR Newswire (US)Bulletin from the Annual General Meeting in Immunovia ABLSE:0G8XImmunovia Ab (publ)
05/23/20232:03AMPR Newswire (US)Immunovia Publishes Interim Report for January-March 2023LSE:0G8XImmunovia Ab (publ)
05/23/20232:00AMPR Newswire (US)Immunovia Publishes Interim Report for January-March 2023LSE:0G8XImmunovia Ab (publ)
05/22/202311:55AMPR Newswire (US)Changes to the Nomination Committee's proposal to the Annual General Meeting 2023 in Immunovia AB (publ)LSE:0G8XImmunovia Ab (publ)
 Showing the most relevant articles for your search:LSE:0G8X

Your Recent History

USOTC
MWWC
Marketing Worldwide (PK)
USOTC
BLLB
Bell Buckle (PK)
USOTC
TKMO
Tekumo (PK)
USOTC
YCRM
Yuenglings Ice Cream (PK)
USOTC
INQD
Indoor Harvest (PK)
USOTC
RSPI
RespireRx Pharmaceuticals (PK)
USOTC
RDGL
Vivos (QB)
USOTC
MONI
Moon Equity (PK)
USOTC
MGON
Megola (PK)
USOTC
UBQU
Ubiquitech Software (PK)
USOTC
UATG
Umbra Applied Technologies (PK)
USOTC
BMXI
Brookmount Explorations (PK)
USOTC
ASRE
Astra Energy (QB)
USOTC
GDVM
Global Developments (PK)
USOTC
ASKH
Astika (PK)
NASDAQ
JAGX
Jaguar Health
Delayed Upgrade Clock
ADVFN Logo

Canada
Company
Business
Popular
Get The App

Support: +44 (0) 203 8794 460 | support@advfn.com

By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions

© 2024 ADVFN PLC - All Rights Reserved